EXI3:XETRA:XETRA-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 354

Change

-12.95 (-3.53)%

Market Cap

USD 0.30B

Volume

2.27K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.17 (-2.78%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.36 (-4.67%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.82 (-3.78%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.36 (-2.90%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.22 (-4.38%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.84 (-3.97%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.50 (-4.20%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.19 (-2.17%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.48 (-4.97%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.05 (+0.04%)

USD 12.26B

ETFs Containing EXI3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.85% 26% F 27% F
Dividend Return -4.26% 77% C+ 28% F
Total Return -17.12% 15% F 17% F
Trailing 12 Months  
Capital Gain -0.83% 50% F 51% F
Dividend Return -4.22% 78% C+ 12% F
Total Return -5.05% 29% F 33% F
Trailing 5 Years  
Capital Gain 81.84% 71% C- 70% C-
Dividend Return -2.18% 81% B- 11% F
Total Return 79.66% 69% C- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.03% 76% C+ 74% C
Dividend Return 13.41% 76% C+ 74% C
Total Return 0.38% 37% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 10.54% 60% D- 68% D+
Risk Adjusted Return 127.26% 98% N/A 98% N/A
Market Capitalization 0.30B 60% D- 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.